HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine

Registos relacionados

• Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial
  Por: Kuhn, Louise, et al.
  Publicado em: (2012)
• Rapid Development of Antiretroviral Drug Resistance Mutations in HIV-Infected Children Less Than Two Years of Age Initiating Protease Inhibitor-Based Therapy in South Africa
  Por: Taylor, Barbara S., et al.
  Publicado em: (2011)
• Re-use of Nevirapine in Exposed HIV-Infected Children After Viral Suppression With a Protease Inhibitor-Based Treatment Regimen: A Randomized Controlled Trial
  Por: Coovadia, Ashraf, et al.
  Publicado em: (2010)
• Persistent Minority K103N Mutations among Women Exposed to Single-Dose Nevirapine and Virologic Response to Nonnucleoside Reverse-Transcriptase Inhibitor–Based Therapy
  Por: Coovadia, Ashraf, et al.
  Publicado em: (2009)
• Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy
  Por: Smith, Kelly, et al.
  Publicado em: (2009)